<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01557803</url>
  </required_header>
  <id_info>
    <org_study_id>MRU-HAS 006/2012</org_study_id>
    <nct_id>NCT01557803</nct_id>
    <nct_alias>NCT01549821</nct_alias>
  </id_info>
  <brief_title>Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome</brief_title>
  <acronym>IRIS</acronym>
  <official_title>Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome in Lambaréné, Gabon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Albert Schweitzer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this project is to determine clinical and biological predictors of Immune
      Reconstitution Inflammatory Syndrome (IRIS) occurrence in HIV infected patients who are
      started on antiretroviral therapy (ART), and to obtain more insight into the pathogenesis of
      this syndrome. The investigators will prospectively study HIV infected patients in Sub
      Saharan Africa who will be initiated on ART and are at risk to develop IRIS in all its
      different appearances. In these patients, the investigators will assess the value of clinical
      features and plasma biomarkers to predict IRIS, and the investigators will obtain insight
      into which inflammatory pathways become activated during IRIS. This project will provide
      novel knowledge about this clinically highly relevant healthcare problem in a resource poor
      setting, namely in Lambaréné, Gabon, in the Central African rainforest belt. In Gabon little
      research has been done in the field of HIV. The epidemiological pattern of IRIS in Gabon will
      be described. Promising putative plasma biomarkers will be validated for their use in daily
      practice.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>IRIS</measure>
    <time_frame>12 months</time_frame>
    <description>Development of immune reconstitution inflammatory syndrome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to IRIS</measure>
    <time_frame>12 months</time_frame>
    <description>Time to development of immune reconstitution inflammatory syndrome</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">107</enrollment>
  <condition>Immune Reconstitution Inflammatory Syndrome</condition>
  <condition>Opportunistic Infections</condition>
  <arm_group>
    <arm_group_label>Starting ART</arm_group_label>
    <description>Adult patients starting anti retroviral therapy for the first time</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma, Paxgene RNA tubes and urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult HIV patients starting anti retroviral therapy for the first time
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Informed consent

          -  ART naive

        Exclusion Criteria:

          -  No informed consent

          -  History of ART use

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MP Grobusch, MD, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Research Unit - Albert Schweitzer Hospital</name>
      <address>
        <city>Lambaréné</city>
        <state>Moyen Ogoué</state>
        <zip>BP118</zip>
        <country>Gabon</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Gabon</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2012</study_first_submitted>
  <study_first_submitted_qc>March 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2012</study_first_posted>
  <last_update_submitted>January 13, 2015</last_update_submitted>
  <last_update_submitted_qc>January 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>S. Janssen</investigator_full_name>
    <investigator_title>MD, MSc</investigator_title>
  </responsible_party>
  <keyword>Immune reconstitution inflammatory syndrome</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>HIV</keyword>
  <keyword>ART</keyword>
  <keyword>predictive factors</keyword>
  <keyword>epidemiological pattern</keyword>
  <keyword>Gabon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Opportunistic Infections</mesh_term>
    <mesh_term>Immune Reconstitution Inflammatory Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

